Skip to main content
. 2024 May 23;8:114. doi: 10.1038/s41698-024-00606-w

Fig. 1. Course of disease.

Fig. 1

Timeline depicting the course of disease and treatment, during which the patient acquired a MYC amplification that was not detected on baseline genetic testing and subsequently developed highly aggressive, immunotherapy-resistant disease. Numbered images at the bottom correspond to the indexes indicated across the course of the disease depicted above. BL: bilateral, EBUS-FNA: endobronchial ultrasound-guided fine-needle aspiration.